Virological Response and Hepatocarcinogenesis in Lamivudine-Resistant Hepatitis B Virus Genotype C Patients Treated with Lamivudine plus Adefovir Dipivoxil

Publisher： Karger

E-ISSN： 1423-0100|51|6|385-393

ISSN： 0300-5526

Source： Intervirology, Vol.51, Iss.6, 2009-02, pp. : 385-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adefovir Dipivoxil for Treatment of Breakthrough Hepatitis Caused by Lamivudine-Resistant Mutants of Hepatitis B Virus

By  

Intervirology, Vol. 47, Iss. 6, 2004-11 ,pp. : 362-369

Karger

Access to resources Recommend Favorite

The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy

By  

Intervirology, Vol. 57, Iss. 6, 2014-09 ,pp. : 337-343

Karger

Access to resources Recommend Favorite

Response to Adefovir Depends on Mutation Patterns in Precore Region, Basal Core Promoter and Reverse Transcriptase, and On-Treatment Responses in Lamivudine-Resistant Chronic Hepatitis B Patients

By  

Intervirology, Vol. 53, Iss. 4, 2010-03 ,pp. : 203-210

Karger

Access to resources Recommend Favorite

Subclones of Drug-Resistant Hepatitis B Virus Mutants and the Outcome of Breakthrough Hepatitis in Patients Treated with Lamivudine

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 350-354

Karger

Access to resources Recommend Favorite

Adefovir and Lamivudine Combination Therapy in Patients with Entecavir-Resistant Chronic Hepatitis B: Antiviral Responses and Evolution of Mutations

By  

Intervirology, Vol. 57, Iss. 5, 2014-06 ,pp. : 239-247

Karger

Access to resources Recommend Favorite